US stock · Healthcare sector · Drug Manufacturers—General
B
Bristol-Myers Squibb Company
BMY
NYSE76.19
USD
+0.23
(+0.30%)
Market Closed
26.99P/E
9Forward P/E
1.04P/E to S&P500
162.213BMarket CAP
2.71%Div Yield
Google Trends
Recent Reddit Comments
Nothing found
Recent Tweets
$BMY All that you need to know,,, Shorts haven't covered a single share.. https://t.co/ZQfr8N4qah
0
0
0
$bmy Another winning alert based on our custom ThinkorSwim script. 🔗 https://t.co/sTLxYeSW9y
0
0
0
$BMY - Bristol-Myers Squibb: A Safe Haven In Times Of Uncertainty. https://t.co/sZz4298m8M #stocks #markets #finance
0
0
1
$BMY
Added a little to my short on retest https://t.co/QuTtKnTRAx
6
1
18
$BMY starting to roll over today finally https://t.co/5uUFijgwDd
0
1
1
$BMY
🇺🇸
BMS {just getting ahead of the news that they've shortened their name}
Bristol Myers Squibb Data at ASCO and EHA 2022 Highlight Progress in Transforming Treatment for Patients with Cancer and Blood Disorders
https://t.co/B0B7yQO9sj https://t.co/vqImbsj2Yg
0
0
0
They gonna ladder $BMY next? https://t.co/s10tWxFdPI
0
0
2
Hmm, with all the hiding spots getting exposed lately, does the double top in $BMY mean they could be next? (Np but want to buy back lower) 🤔 https://t.co/SWcKDkHfXe
1
0
0
$PPBT $BMY - Purple Biotech initiates phase 2 study for its antibody CM24 in pancreatic cancer patients https://t.co/7XM9ugRdR6
0
1
4
$BMY
Possible short set up brewing. https://t.co/npytdmMPW1
6
4
22
$BMY
Looking much like $MRK did a couple of weeks ago before it made its nice run. Price is holding up well with today's volatility. I've got a pilot position. Would like it to settle and start building another base to potentially by more in the coming days. We will see.. https://t.co/fNqy9Qv6j0
2
0
5
$BMY has found support at green line and gone to ATH as has $MRK. I sell anything that CLOSES back below its green line break-out (GLB). Anything that can come through this market at ATH is worth researching. This message is for educational purposes only. https://t.co/DvZ0EzhR5n
6
10
72
After 20 years of absolutely no progress, these healthcare stocks are finally trying to break out of their multi-decade base.
$MRK $PFE $BMY https://t.co/NSto0QpSHE
8
55
226
20
25
145
$BMY
Possible cheat setup here with Bristol-Myers Squibb. The stock is contracting well and beginning to form a mini coil. I'd watch it, very strong. https://t.co/vEfHkLnT85
1
0
3
$BMY I don't much believe in coincidence. Price (human) behavior is repetitive..think the breakout crowd is setting itself up for disappointment https://t.co/SZguNxhYQS
0
0
1
$BMY Phase 3 CheckMate -901 trial comparing Opdivo plus Yervoy as a first-line treatment for patients with untreated unresectable or metastatic urothelial carcinoma, did not meet the primary endpoint of overall survival (OS).
0
1
5
5
7
66
9
10
68